|
DE2927352A1
(de)
|
1979-07-06 |
1981-02-05 |
Thomae Gmbh Dr K |
In 6-stellung substituierte benzothiazol-2(3h)-one enthaltende arzneimittel
|
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
|
GB8817743D0
(en)
|
1988-07-26 |
1988-09-01 |
Fujisawa Pharmaceutical Co |
Fr901228 substance & preparation thereof
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US5545522A
(en)
|
1989-09-22 |
1996-08-13 |
Van Gelder; Russell N. |
Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
|
|
US5817667A
(en)
*
|
1991-04-17 |
1998-10-06 |
University Of Georgia Research Foudation |
Compounds and methods for the treatment of cancer
|
|
JPH064872A
(ja)
|
1992-06-19 |
1994-01-14 |
Sony Corp |
光ディスク再生装置
|
|
JPH0764872A
(ja)
|
1993-08-26 |
1995-03-10 |
Fujitsu Ten Ltd |
データ記憶制御装置
|
|
US5578832A
(en)
|
1994-09-02 |
1996-11-26 |
Affymetrix, Inc. |
Method and apparatus for imaging a sample on a device
|
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US5776905A
(en)
|
1996-08-08 |
1998-07-07 |
The Board Of Trustees Of The Leland Stamford Junior University |
Apoptotic regression of intimal vascular lesions
|
|
US6030961A
(en)
|
1997-03-11 |
2000-02-29 |
Bar-Ilan Research & Development Co., Ltd. |
Oxyalkylene phosphate compounds and uses thereof
|
|
US6124495A
(en)
|
1997-03-11 |
2000-09-26 |
Beacon Laboratories, Inc. |
Unsaturated oxyalkylene esters and uses thereof
|
|
WO1999011659A1
(en)
|
1997-09-02 |
1999-03-11 |
Japan Energy Corporation |
Novel cyclic tetrapeptide derivatives and medicinal use thereof
|
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
|
JPH11335375A
(ja)
|
1998-05-20 |
1999-12-07 |
Mitsui Chem Inc |
ヒストン脱アセチル化酵素阻害作用を有するベンズアミド誘導体
|
|
US6214986B1
(en)
|
1998-10-07 |
2001-04-10 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of bcl-x expression
|
|
US20070148228A1
(en)
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
|
US6723338B1
(en)
|
1999-04-01 |
2004-04-20 |
Inex Pharmaceuticals Corporation |
Compositions and methods for treating lymphoma
|
|
NZ517613A
(en)
|
1999-09-08 |
2004-01-30 |
Sloan Kettering Inst Cancer |
Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
|
|
US6828302B1
(en)
|
1999-12-08 |
2004-12-07 |
Xcyte Therapies, Inc. |
Therapeutic uses of depsipeptides and congeners thereof
|
|
CN1414971A
(zh)
|
1999-12-08 |
2003-04-30 |
埃克斯西特治疗公司 |
用作免疫抑制剂的缩肽及其同类物
|
|
CA2317003A1
(en)
|
2000-02-28 |
2001-08-28 |
Hidenori Nakajima |
Gene expression potentiator
|
|
JP2001348340A
(ja)
|
2000-06-07 |
2001-12-18 |
Yamanouchi Pharmaceut Co Ltd |
ヒストン脱アセチル化酵素阻害剤
|
|
ATE425177T1
(de)
|
2000-07-17 |
2009-03-15 |
Astellas Pharma Inc |
Reduziertes fk228 und seine verwendung
|
|
WO2002015921A2
(en)
|
2000-08-18 |
2002-02-28 |
The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor
|
|
WO2002020817A1
(en)
|
2000-09-01 |
2002-03-14 |
Fujisawa Pharmaceutical Co., Ltd. |
A method of producing fr901228
|
|
AU2002243231A1
(en)
|
2000-11-21 |
2002-07-24 |
Wake Forest University |
Method of treating autoimmune diseases
|
|
AU2002249938B2
(en)
|
2001-01-10 |
2006-12-21 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
|
|
US7219016B2
(en)
|
2001-04-20 |
2007-05-15 |
Yale University |
Systems and methods for automated analysis of cells and tissues
|
|
US6905669B2
(en)
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
|
EP1390491B1
(en)
|
2001-05-02 |
2008-07-16 |
The Regents of the University of California |
Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
|
|
WO2002097053A2
(en)
|
2001-05-30 |
2002-12-05 |
The Regents Of The University Of Michigan |
Small molecule antagonists of bcl2 family proteins
|
|
US7171311B2
(en)
|
2001-06-18 |
2007-01-30 |
Rosetta Inpharmatics Llc |
Methods of assigning treatment to breast cancer patients
|
|
JP4238728B2
(ja)
|
2001-08-21 |
2009-03-18 |
アステラス製薬株式会社 |
ヒストンデアセチラーゼ阻害剤の医薬用途ならびにその抗腫瘍効果の評価方法
|
|
WO2003017763A1
(en)
|
2001-08-24 |
2003-03-06 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell
|
|
EP1293205A1
(en)
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
|
US6706686B2
(en)
|
2001-09-27 |
2004-03-16 |
The Regents Of The University Of Colorado |
Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
|
|
WO2003035843A2
(en)
|
2001-10-25 |
2003-05-01 |
Buck Institute For Age Research |
Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
|
|
WO2003038060A2
(en)
|
2001-11-01 |
2003-05-08 |
The Regents Of The University Of Michigan |
Small molecule inhibitors targeted at bcl-2
|
|
WO2003053468A1
(en)
|
2001-12-21 |
2003-07-03 |
Universite Libre De Bruxelles |
Method for obtaining the elimination of integrated and functional viruses from infected mammal cells
|
|
US20030134423A1
(en)
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
|
JP2005525345A
(ja)
|
2002-02-15 |
2005-08-25 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
Ｔｒｘ媒介性疾患を処置する方法
|
|
AU2003211576A1
(en)
|
2002-02-20 |
2003-09-09 |
Sueharu Horinouchi |
Histone deacetylase inhibitors and process for producing the same
|
|
CN101259120B
(zh)
|
2002-03-04 |
2012-07-04 |
Hdac默克研究有限责任公司 |
辛二酰苯胺异羟肟酸或其可药用盐在制备诱导末期分化的药物的用途
|
|
US20040132825A1
(en)
|
2002-03-04 |
2004-07-08 |
Bacopoulos Nicholas G. |
Methods of treating cancer with HDAC inhibitors
|
|
AU2003226014A1
(en)
|
2002-03-28 |
2003-10-13 |
Brigham And Women's Hospital, Inc. |
Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
|
|
US8673888B2
(en)
|
2002-04-05 |
2014-03-18 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Depsipeptide for therapy of kidney cancer
|
|
AU2003226408B2
(en)
|
2002-04-15 |
2007-06-14 |
Sloan-Kettering Institute For Cancer Research |
Combination therapy for the treatment of cancer
|
|
US6809118B2
(en)
|
2002-07-25 |
2004-10-26 |
Yih-Lin Chung |
Methods for therapy of radiation cutaneous syndrome
|
|
US20040002447A1
(en)
|
2002-06-04 |
2004-01-01 |
Regents Of The University Of California |
Induction of insulin expression
|
|
US20050065596A1
(en)
|
2002-07-24 |
2005-03-24 |
Xufan Tseng |
Stents capable of controllably releasing histone deacetylase inhibitors
|
|
JP4804004B2
(ja)
|
2002-08-20 |
2011-10-26 |
アステラス製薬株式会社 |
関節軟骨細胞外マトリクス分解阻害剤
|
|
CN1681505A
(zh)
|
2002-09-13 |
2005-10-12 |
弗吉尼亚州立大学 |
用于治疗白血病的а ) N－{ 5－[ 4－( 4－甲基－哌嗪－1－基－甲基)－苯甲酰氨基]－2－甲基苯基}－4－( 3－吡啶基 ) －2－嘧啶－胺和b )组蛋白脱乙酰基酶抑制剂的组合
|
|
SE0300098D0
(sv)
|
2003-01-15 |
2003-01-15 |
Forskarpatent I Syd Ab |
Use of cyclin D1 inhibitors
|
|
WO2004064727A2
(en)
|
2003-01-16 |
2004-08-05 |
Georgetown University |
Method of cancer treatment using hdac inhibitors
|
|
EP1595952A4
(en)
|
2003-02-19 |
2008-05-21 |
Astellas Pharma Inc |
METHOD FOR EVALUATING THE ANTITUMOR EFFECT OF A HISTONE DEACETYLASE INHIBITOR
|
|
JP4588634B2
(ja)
|
2003-04-25 |
2010-12-01 |
尚巳 岡田 |
遺伝子導入効率増強剤および商業的パッケージ
|
|
US20040213826A1
(en)
|
2003-04-28 |
2004-10-28 |
Marx Steven O. |
Medical devices and methods for inhibiting proliferation of smooth muscle cells
|
|
EP1491188A1
(en)
|
2003-06-25 |
2004-12-29 |
G2M Cancer Drugs AG |
Topical use of valproic acid for the prevention or treatment of skin disorders
|
|
SI2238982T1
(sl)
|
2003-06-27 |
2013-01-31 |
Astellas Pharma Inc. |
Terapevtsko sredstvo za mehkotkivni sarkom
|
|
EP1663978B1
(en)
|
2003-07-23 |
2007-11-28 |
Bayer Pharmaceuticals Corporation |
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
AU2003268185A1
(en)
*
|
2003-08-25 |
2005-04-11 |
Dana-Farber Cancer Institute Inc. |
Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
|
|
SI1663194T1
(sl)
|
2003-08-26 |
2010-08-31 |
Merck Hdac Res Llc |
Uporaba SAHA za zdravljenje mezotelioma
|
|
CN102349927A
(zh)
|
2003-08-29 |
2012-02-15 |
Hdac默克研究有限责任公司 |
联合治疗癌症的方法
|
|
US20050059682A1
(en)
|
2003-09-12 |
2005-03-17 |
Supergen, Inc., A Delaware Corporation |
Compositions and methods for treatment of cancer
|
|
MXPA06003066A
(es)
|
2003-09-18 |
2006-06-20 |
Combinatorx Inc |
Combinaciones de farmacos para el tratamiento de neoplasmas.
|
|
ES2425083T3
(es)
|
2003-09-25 |
2013-10-11 |
Astellas Pharma Inc. |
Agente antitumoral que comprende FK228 como inhibidor de histona desacetilasa y doxorrubicina como inhibidor de topoisomerasa II
|
|
US8614318B2
(en)
|
2003-11-13 |
2013-12-24 |
Abbvie Inc. |
Apoptosis promoters
|
|
CA2546178A1
(en)
|
2003-11-14 |
2005-06-09 |
Per Sonne Holm |
New use of adenovirus and nucleic acids coding therefor
|
|
EP1689446B1
(de)
|
2003-11-14 |
2015-01-07 |
Per Sonne Holm |
Neue adenoviren, dafür codierende nukleinsäuren und deren verwendung
|
|
WO2005053609A2
(en)
|
2003-11-26 |
2005-06-16 |
Guilford Pharmaceuticals Inc. |
Methods of nad+-dependent deacetylase inhibitors
|
|
WO2005058298A2
(en)
|
2003-12-10 |
2005-06-30 |
Wisconsin Alumni Research Foundation |
Fk228 analogs and their use as hdac-inhibitors
|
|
US7951780B2
(en)
|
2004-02-25 |
2011-05-31 |
Astellas Pharma Inc. |
Antitumor agent
|
|
US20050187148A1
(en)
|
2004-02-25 |
2005-08-25 |
Yoshinori Naoe |
Antitumor agent
|
|
DE602005015559D1
(de)
|
2004-02-27 |
2009-09-03 |
Us Gov Health & Human Serv |
Pharmakodynamische tests mit durchflusszytometrie
|
|
GB0405349D0
(en)
|
2004-03-10 |
2004-04-21 |
Univ Birmingham |
Cancer therapy and medicaments therefor
|
|
ITMI20040876A1
(it)
|
2004-04-30 |
2004-07-30 |
Univ Degli Studi Milano |
Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
|
|
DK1591109T3
(da)
|
2004-04-30 |
2008-10-06 |
Topotarget Germany Ag |
Formulering, der omfatter histondeacetylaseinhibitorer, der udviser tofaset frigivelse
|
|
US20050261174A1
(en)
|
2004-05-20 |
2005-11-24 |
Paul Lewer |
Insecticidal activity of a cyclic peptide
|
|
WO2005117930A2
(en)
|
2004-06-04 |
2005-12-15 |
Sloan-Kettering Institute For Cancer Research |
Use of thioredoxin measurements for diagnostics and treatments
|
|
WO2005123089A2
(en)
|
2004-06-10 |
2005-12-29 |
Kalypsys, Inc. |
Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
|
|
US20060018921A1
(en)
|
2004-07-16 |
2006-01-26 |
Baylor College Of Medicine |
Histone deacetylase inhibitors and cognitive applications
|
|
ES2368930T3
(es)
|
2004-09-06 |
2011-11-23 |
Bayer Pharma Aktiengesellschaft |
Pirazolopirimidinas como inhibidores de proteína cinasa b (akt).
|
|
WO2006055621A2
(en)
|
2004-11-17 |
2006-05-26 |
The University Of Chicago |
Histone deacetylase inhibitors and methods of use
|
|
WO2006060382A2
(en)
|
2004-11-30 |
2006-06-08 |
Trustees Of The University Of Pennsylvania |
Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
|
|
WO2006060429A2
(en)
|
2004-12-03 |
2006-06-08 |
Novartis Ag |
Identification of variants in histone deacetylase 1 (hdac1) to predict drug response
|
|
US20060128660A1
(en)
|
2004-12-10 |
2006-06-15 |
Wisconsin Alumni Research Foundation |
FK228 analogs and methods of making and using the same
|
|
GB0511266D0
(en)
|
2005-06-02 |
2005-07-13 |
Trust |
Chemical compounds
|
|
EP1743654A1
(en)
|
2005-07-15 |
2007-01-17 |
TopoTarget Germany AG |
Use of inhibitors of histone deacetylases in combination with NSAID for the therapy of cancer and/or inflammatory diseases
|
|
US7943568B2
(en)
|
2005-09-30 |
2011-05-17 |
The Ohio State University Research Foundation |
Antitumor agents
|
|
US20090325156A1
(en)
|
2005-11-10 |
2009-12-31 |
Government of the United States of America, as Represented by Secretary, Dept. of Human Services |
Materials and methods for abcb1 polymorphic variant screening, diagnosis, and treatment
|
|
US20070129290A1
(en)
|
2005-11-18 |
2007-06-07 |
Or Yat S |
Metabolite derivatives of the HDAC inhibitor FK228
|
|
EP2012801A4
(en)
|
2006-04-24 |
2009-08-05 |
Gloucester Pharmaceuticals Inc |
GEMCITABINE COMBINATION THERAPY
|
|
US8957027B2
(en)
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
|
JP2009539862A
(ja)
|
2006-06-09 |
2009-11-19 |
メリオン リサーチ Ｉｉｉ リミテッド |
強化剤を含む固体経口投与剤形
|
|
US7857804B2
(en)
|
2006-09-01 |
2010-12-28 |
Mccaffrey Timothy A |
Use of Bcl inhibitors for the prevention of fibroproliferative reclosure of dilated blood vessels and other iatrogenic fibroproliferative disorders
|
|
CN101687010A
(zh)
*
|
2006-12-29 |
2010-03-31 |
格洛斯特制药公司 |
制备Romidepsin
|
|
AU2007342028B2
(en)
|
2006-12-29 |
2013-06-13 |
Celgene Corporation |
Purifiction of romidepsin
|
|
WO2009064300A1
(en)
*
|
2007-11-15 |
2009-05-22 |
The Johns Hopkins University |
Combinations of hdac inhibitors and cytokines/growth factors
|
|
EP2309854A4
(en)
*
|
2008-07-30 |
2012-06-06 |
Gloucester Pharmaceuticals Inc |
ACCELERATED THERAPY:
|